These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 19459409)

  • 1. [Effects of novel antiviral agents on HIV-1 replication].
    Vorkunova GK; Kalnina LB; Burshteĭn ME; Serbin AV; Rodionov IL; Pavlova MV; Bukrinskaia AG
    Vopr Virusol; 2009; 54(2):27-31. PubMed ID: 19459409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HIV-inhibiting activity of polyanion matrices and related substances containing adamantane and norbornene pharmacophores].
    Timofeev DI; Perminova NG; Serbin AV; Kiseleva IaIu; Nekliudov VV; Vatolin GIu; Kas'ian LI; Grebinik TS; Timofeev IV
    Antibiot Khimioter; 2003; 48(5):33-41. PubMed ID: 12968467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of HIV-1 replication by newly developed adamantane-containing polyanionic agents.
    Burstein ME; Serbin AV; Khakhulina TV; Alymova IV; Stotskaya LL; Bogdan OP; Manukchina EE; Jdanov VV; Sharova NK; Bukrinskaya AG
    Antiviral Res; 1999 Apr; 41(3):135-44. PubMed ID: 10320046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiviral action of membranotropic compounds modified by adamantane and norbornene pharmacophores exerted on different HIV-1 strains].
    Kiseleva IaIu; Perminova NG; liasunova OA; Timofeev DI; Serbin AV; Kas'ian LI; Egorov IuA; Grebinik TS; Timofeev IV
    Mol Gen Mikrobiol Virusol; 2005; (2):33-6. PubMed ID: 15954475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human immunodeficiency virus type 1 replication by the K10-K42 peptide of GAP31 is due to induction of rapid but nonspecific precipitation of viral and nonviral proteins.
    Fink PD; Alexander IE; Rowe PB; Smythe JA
    AIDS Res Hum Retroviruses; 1999 Mar; 15(5):429-34. PubMed ID: 10195752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-HIV-1 activity of anti-TAR polyamide nucleic acid conjugated with various membrane transducing peptides.
    Tripathi S; Chaubey B; Ganguly S; Harris D; Casale RA; Pandey VN
    Nucleic Acids Res; 2005; 33(13):4345-56. PubMed ID: 16077030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent inhibition of HIV-1 replication by backbone cyclic peptides bearing the Rev arginine rich motif.
    Chaloin L; Smagulova F; Hariton-Gazal E; Briant L; Loyter A; Devaux C
    J Biomed Sci; 2007 Sep; 14(5):565-84. PubMed ID: 17520355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-HIV activity of N-1-adamantyl-4-aminophthalimide.
    Van Derpoorten K; Balzarini J; De Clercq E; Poupaert JH
    Biomed Pharmacother; 1997; 51(10):464-8. PubMed ID: 9863507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiviral activity of polycarboxylic substances modified by cage hydrocarbon and sulfoacid pharmacophors against cytomegalovirus infection in vitro].
    Pavlova MV; Fedorova NE; Serbin AV; Egorov IuA; Karaseva EN; Klimova EV; Kushch AA
    Antibiot Khimioter; 2008; 53(7-8):8-14. PubMed ID: 19227117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation.
    Dis Markers; 1990; 8(3):162-3. PubMed ID: 2125537
    [No Abstract]   [Full Text] [Related]  

  • 11. Backbone cyclic peptide, which mimics the nuclear localization signal of human immunodeficiency virus type 1 matrix protein, inhibits nuclear import and virus production in nondividing cells.
    Friedler A; Zakai N; Karni O; Broder YC; Baraz L; Kotler M; Loyter A; Gilon C
    Biochemistry; 1998 Apr; 37(16):5616-22. PubMed ID: 9548947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle.
    Witvrouw M; Fikkert V; Pluymers W; Matthews B; Mardel K; Schols D; Raff J; Debyser Z; De Clercq E; Holan G; Pannecouque C
    Mol Pharmacol; 2000 Nov; 58(5):1100-8. PubMed ID: 11040059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synthetic CD4 exocyclic CDR3.AME(82-89) inhibits NF-kappaB nuclear translocation, HIV-1 promoter activation, and viral gene expression.
    Roland J; Berezov A; Greene MI; Murali R; Piatier-Tonneau D; Devaux C; Briant L
    DNA Cell Biol; 1999 Nov; 18(11):819-28. PubMed ID: 10595395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide, peptidomimetic and small-molecule drug discovery targeting HIV-1 host-cell attachment and entry through gp120, gp41, CCR5 and CXCR4.
    Kazmierski WM; Kenakin TP; Gudmundsson KS
    Chem Biol Drug Des; 2006 Jan; 67(1):13-26. PubMed ID: 16492145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs.
    Kashanchi F; Sadaie MR; Brady JN
    Virology; 1997 Jan; 227(2):431-8. PubMed ID: 9018142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNase S complex bearing arginine-rich peptide and anti-HIV activity.
    Futaki S; Nakase I; Suzuki T; Nameki D; Kodama E; Matsuoka M; Sugiura Y
    J Mol Recognit; 2005; 18(2):169-74. PubMed ID: 15476294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of amino acid replacements, additions and deletions on the antiviral activity of a peptide derived from the HIV-1 GP41 sequence.
    Jiang S; Lin K
    Pept Res; 1995; 8(6):345-8. PubMed ID: 8838418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of HIV-1 replication and syncytium formation by synthetic CD4 peptides.
    Hayashi Y; Ikuta K; Fujii N; Ezawa K; Kato S
    Arch Virol; 1989; 105(1-2):129-35. PubMed ID: 2785788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of structural protein Gag and related gene (protein) in late stages of the HIV-1 replication cycle and the inhibitors].
    Jiang Y; Liu XY
    Yao Xue Xue Bao; 2010 Feb; 45(2):205-14. PubMed ID: 21351430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
    BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
    J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.